IL98762A - Diaminotri history - fluoromethylpyridine, process for their production and phospholipase A2 inhibitors that contain them - Google Patents

Diaminotri history - fluoromethylpyridine, process for their production and phospholipase A2 inhibitors that contain them

Info

Publication number
IL98762A
IL98762A IL9876291A IL9876291A IL98762A IL 98762 A IL98762 A IL 98762A IL 9876291 A IL9876291 A IL 9876291A IL 9876291 A IL9876291 A IL 9876291A IL 98762 A IL98762 A IL 98762A
Authority
IL
Israel
Prior art keywords
substituted
alkyl
phenyl
independent
hydrocarbon group
Prior art date
Application number
IL9876291A
Other languages
English (en)
Hebrew (he)
Other versions
IL98762A0 (en
Original Assignee
Ishihara Sangyo Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3222530A external-priority patent/JPH05170742A/ja
Application filed by Ishihara Sangyo Kaisha filed Critical Ishihara Sangyo Kaisha
Publication of IL98762A0 publication Critical patent/IL98762A0/xx
Publication of IL98762A publication Critical patent/IL98762A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL9876291A 1990-07-10 1991-07-08 Diaminotri history - fluoromethylpyridine, process for their production and phospholipase A2 inhibitors that contain them IL98762A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18199990 1990-07-10
JP3222530A JPH05170742A (ja) 1991-05-24 1991-05-24 ジアミノトリフルオロメチルピリジン誘導体、それらの製造方法及びそれらを含有するホスホリパーゼ▲ａ２▼阻害剤

Publications (2)

Publication Number Publication Date
IL98762A0 IL98762A0 (en) 1992-07-15
IL98762A true IL98762A (en) 1995-05-26

Family

ID=26500966

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9876291A IL98762A (en) 1990-07-10 1991-07-08 Diaminotri history - fluoromethylpyridine, process for their production and phospholipase A2 inhibitors that contain them

Country Status (14)

Country Link
EP (1) EP0465913B1 (ja)
JP (3) JP2762323B2 (ja)
KR (1) KR0173311B1 (ja)
CN (1) CN1032534C (ja)
AT (1) ATE157969T1 (ja)
AU (1) AU642267B2 (ja)
CA (1) CA2045857C (ja)
DE (1) DE69127595T2 (ja)
DK (1) DK0465913T3 (ja)
ES (1) ES2107434T3 (ja)
GR (1) GR3025455T3 (ja)
HK (1) HK1001839A1 (ja)
IL (1) IL98762A (ja)
NZ (1) NZ238752A (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465913B1 (en) * 1990-07-10 1997-09-10 Ishihara Sangyo Kaisha, Ltd. Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them
GB9403333D0 (en) * 1994-02-22 1994-04-13 Zeneca Ltd Compound and use
FR2720396B1 (fr) * 1994-05-27 1996-06-28 Adir Nouveaux N-pyridyl carboxamides et dérivés leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ID18983A (id) * 1996-12-04 1998-05-28 Lilly Co Eli Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia
ZA981430B (en) * 1997-02-28 1998-08-24 Ishihara Sangyo Kaisha Anticancer composition
WO2001056569A1 (fr) * 2000-02-01 2001-08-09 Ishihara Sangyo Kaisha, Ltd. Medicaments pour le traitement et la prevention d'affections hepatiques, a base de derives de diaminotrifluoromethylpyridine
JP4848092B2 (ja) * 2000-02-01 2011-12-28 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤
EP1557670A4 (en) * 2002-10-30 2007-03-07 Ishihara Sangyo Kaisha REGULATION OF INTERACTIONS BETWEEN RAPL AND RAP1
JP5584518B2 (ja) 2009-05-28 2014-09-03 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤
EP2923710A1 (en) 2014-03-27 2015-09-30 Universitätsklinikum Heidelberg Bacterial phospholipase inhibitors as modulator of colonic bacterial flora
CA3081177A1 (en) 2017-11-02 2019-05-09 Ishihara Sangyo Kaisha, Ltd. Sustained-release pharmaceutical composition
EP3760200A4 (en) * 2018-03-01 2021-12-15 Ishihara Sangyo Kaisha, Ltd. PHARMACEUTICAL COMPOSITION WITH EXCELLENT STABILITY IN STORAGE
US20220306582A1 (en) * 2019-05-15 2022-09-29 Ishihara Sangyo Kaisha, Ltd. Anhydrous Crystal of Monosodium N-(2-Ethylsulfonylamino-5-Trifluoromethyl-3-Pyridyl)Cyclohexane Carboxamide
KR102188659B1 (ko) 2019-12-10 2020-12-08 박영식 핸드 파렛트 트럭용 전도방지장치
KR20230084205A (ko) 2020-09-29 2023-06-12 이시하라 산교 가부시끼가이샤 우수한 보존 효력을 나타내는 액상 의약 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962263A (en) 1970-03-20 1976-06-08 Eli Lilly And Company N-(2,2-difluoroalkanoyl)-2,3-pyridinediamine compounds
FR2124163A1 (en) * 1971-02-10 1972-09-22 Ferlux 2-amino-3-hydroxypyridine derivs - cardiovascular active
US3963660A (en) * 1973-10-04 1976-06-15 The Upjohn Company Pyridine dioxamic acids and esters
US3961063A (en) 1975-04-03 1976-06-01 Smithkline Corporation 2,3-Bis-(3-acyl-2-thioureido)-pyridines
EP0465913B1 (en) * 1990-07-10 1997-09-10 Ishihara Sangyo Kaisha, Ltd. Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them

Also Published As

Publication number Publication date
JP2762323B2 (ja) 1998-06-04
HK1001839A1 (en) 1998-07-10
GR3025455T3 (en) 1998-02-27
JPH06263735A (ja) 1994-09-20
JP3078896B2 (ja) 2000-08-21
JPH10152473A (ja) 1998-06-09
EP0465913A2 (en) 1992-01-15
EP0465913A3 (en) 1992-04-15
KR0173311B1 (ko) 1999-02-01
DE69127595D1 (de) 1997-10-16
CN1032534C (zh) 1996-08-14
CA2045857A1 (en) 1992-01-11
AU7949791A (en) 1992-01-16
CA2045857C (en) 1997-09-23
JP3048344B2 (ja) 2000-06-05
JPH06247934A (ja) 1994-09-06
EP0465913B1 (en) 1997-09-10
DE69127595T2 (de) 1998-01-22
DK0465913T3 (da) 1997-10-20
ES2107434T3 (es) 1997-12-01
AU642267B2 (en) 1993-10-14
KR920002546A (ko) 1992-02-28
ATE157969T1 (de) 1997-09-15
CN1058396A (zh) 1992-02-05
IL98762A0 (en) 1992-07-15
NZ238752A (en) 1993-06-25

Similar Documents

Publication Publication Date Title
AU648423B2 (en) Therapeutic amides
EP0465913B1 (en) Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them
KR100418808B1 (ko) 금속단백질분해효소억제제
KR20070091634A (ko) 염증 치료시 ｃｘｃｒ2 억제제로서 사용하기 위한 융합된비사이클릭 카복스아미드 유도체
EA009201B1 (ru) Фенил - или пиридиламидные соединения в качестве антагонистов простагландина e2
US6313153B1 (en) Compositions and methods for treating nephritis and inhibiting TGF -β related conditions using pyridylacrylamide derivatives
AU4622399A (en) 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them
JPH06135934A (ja) ピリジン誘導体又はその塩を含有するホスホリパーゼ▲ａ２▼阻害剤、抗炎症剤又は抗膵炎剤
RU2057123C1 (ru) Производные диаминотрифторметилпиридина или их соли со щелочными или щелочноземельными металлами и фармацевтическая композиция, ингибирующая фосфолипазу a2
KR960011371B1 (ko) 피리딘-2,4-및-2,5-디카복실산 유도체, 이의 제조방법, 이의 용도, 및 이들 화합물을 기본으로 하는 약제
JP3140494B2 (ja) 置換されたフエニルアセチレン、これを含有する薬剤、この化合物及び薬剤を製造する方法
JPH06145145A (ja) アミノトリフルオロメチルピリジン誘導体又はその塩、それらの製造方法及びそれらを含有するホスホリパーゼａ▲２▼阻害剤、抗炎症剤並びに抗膵炎剤
US20050187264A1 (en) Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
JPH06122669A (ja) ジアミノベンゼン誘導体を含有するホスホリパーゼａ２阻害剤
JPH05170742A (ja) ジアミノトリフルオロメチルピリジン誘導体、それらの製造方法及びそれらを含有するホスホリパーゼ▲ａ２▼阻害剤
FR2462438A1 (fr) Nouveaux derives de la 6-alkyl-7-phenyl-1,6-naphtyridine-5(6h)-one, leur preparation et leur application comme medicaments
WO2024145931A1 (zh) β-catenin/BCL9蛋白蛋白相互作用的小分子抑制剂及其应用
CA2345997A1 (en) Benzamide derivatives as thrombin inhibitors
RU2074173C1 (ru) Амиды, способы их получения и фармацевтическая композиция, обладающая свойствами открывателя каналов для клеточного калия
US4542140A (en) Pyridinyl substituted ketenemercaptal derivatives
NZ241505A (en) 2,4- and 2,5- bistetrazolylpyridine derivative, preparation and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired